Trial · NCT07904585
Comparison of Ultrasound-Guided Erector Spinae Plane Block and Quadro-Iliac Plane Block in Elective Primary Unilateral Total Hip Arthroplasty
NCT07904585, Not applicable, Not yet recruiting, Uludag University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Comparison of Ultrasound-Guided Erector Spinae Plane Block and Quadro-Iliac Plane Block in Elective Primary Unilateral Total Hip Arthroplasty. Trials, record NCT07904585. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07904585
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Comparison of Ultrasound-Guided Erector Spinae Plane Block and Quadro-Iliac Plane Block in Elective Primary Unilateral Total Hip Arthroplasty
- NCT number
- NCT07904585
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 80 participants, estimated
- Lead sponsor
- Uludag University
- Conditions
- Postoperative Pain, Hip Arthroplasty, Total
- Interventions
- Quadro-Iliac Plane Block (QIPB), Erector Spinae Plane Block
- First posted
- 2026-10-29
- Last updated
- 2026-11-03
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Cumulative opioid consumption in the first 24 postoperative hours | First 24 hours after surgery | Total opioid consumption (PCA and additional rescue morphine), determined from PCA device records and converted to intravenous morphine equivalents (mg). |
| Secondary | Quality of Recovery-15 (QoR-15) score | Postoperative 24th hour | The Quality of Recovery-15 (QoR-15) is a validated patient-reported measure of the quality of recovery after surgery and anesthesia. It has 15 items, each scored from 0 to 10, giving a total score of 0 to 150; higher scores indicate better recovery. The items cover five dimensions: physical comfort, physical independence, psychological support, emotional state and pain, and negative items are reverse-scored. Total scores are commonly interpreted as excellent (136-150), good (122-135), moderate (90-121) or poor (0-89). The validated Turkish version is used. It is administered preoperatively (baseline) and at postoperative hour 24; the outcome is the total score at hour 24 and its change from the preoperative baseline value. |
| Secondary | Pain intensity at rest (Numeric Rating Scale, NRS) | PACU arrival and postoperative hours 2, 6, 12, 24, 36 and 48 | The Numeric Rating Scale (NRS) is a validated, self-reported measure of pain intensity. Patients rate their pain on an 11-point scale from 0 (no pain) to 10 (unbearable pain); higher scores indicate more severe pain. Pain at rest is recorded at each time point listed in the time frame. |
| Secondary | Pain intensity with movement (Numeric Rating Scale, NRS) | PACU arrival and postoperative hours 2, 6, 12, 24, 36 and 48 | The Numeric Rating Scale (NRS) is a validated, self-reported measure of pain intensity. Patients rate their pain on an 11-point scale from 0 (no pain) to 10 (unbearable pain); higher scores indicate more severe pain. Pain with movement is assessed during passive 45-degree flexion of the operated hip at each time point listed in the time frame. |
| Secondary | Time to first rescue analgesia | First 48 hours after surgery | Time from the end of surgery to the first PCA request. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07904585
GET https://conductscience.org/api/trials/v1/NCT07904585/registered